Markets & Stocks
Jazz Pharma Wards Off Epidiolex Patent Challenges, Hellenic Fights for Survival in Court, & OCT Rebrands to Octavian
Earlier this week, Jazz dismissed a patent claim against Apotex, Canada’s largest generic drug producer, as it reached a settlement with the company, the details of which were undisclosed.